{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T22:21:36Z","timestamp":1759616496362},"reference-count":21,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":3471,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Paediatrica"],"published-print":{"date-parts":[[2006,3,1]]},"DOI":"10.1080\/08035250500423804","type":"journal-article","created":{"date-parts":[[2006,2,22]],"date-time":"2006-02-22T19:09:18Z","timestamp":1140635358000},"page":"312-317","source":"Crossref","is-referenced-by-count":17,"title":["Ten years\u2019 experience of enzyme infusion therapy of Norrbottnian (type 3) Gaucher disease"],"prefix":"10.1111","volume":"95","author":[{"given":"Anders","family":"Erikson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H\u00e5kan","family":"Forsberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magnus","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marianne","family":"\u00c5str\u00f6m","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan-Eric","family":"M\u00e5nsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","reference":[{"key":"E00001","first-page":"3635","author":"BeutlerE","year":"2001","unstructured":"Beutler, E and Grabowski, GA.(2001) Gaucher disease. In <i>The metabolic and molecular bases of inherited disease<\/i>. ( pp. 3635 - 68 ). New York : McGraw-Hill."},{"key":"E00002","first-page":"395","author":"KnudsonAG","year":"1962","unstructured":"Knudson, AG, Jr and Kaplan, WD.(1962) Genetics of sphingolipidoses. In <i>Cerebral sphingolipidoses<\/i>. ( pp. 395 - 411 ). New York : Academic Press."},{"key":"E00003","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1007\/s00018-002-8458-y","volume":"59","author":"Zhao H","year":"2002","unstructured":"Zhao, H and Grabowski, GA. (2002) Gaucher disease: perspectives on a prototype lysosomal disease <i>Cell Mol Life Sci<\/i>, 59, pp. 694 - 707.","journal-title":"Cell Mol Life Sci"},{"key":"E00004","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/j.1471-4159.1982.tb07950.x","volume":"39","author":"Nilsson O","year":"1982","unstructured":"Nilsson, O and Svennerholm, L. (1982) Accumulation of glucosylceramide and glucosylsphingosine (psychosine) in cerebrum and cerebellum in infantile and juvenile Gaucher disease <i>J Neurochem<\/i>, 39, pp. 709 - 18.","journal-title":"J Neurochem"},{"key":"E00005","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S1096-7192(02)00117-8","volume":"76","author":"Orvisky E","year":"2002","unstructured":"Orvisky, E and Park, JK and LaMarca, ME and Ginns, EI and Martin, BM and Tayebi, N and (2002) Glucosylsphingosine accumulation in tissues from patients with Gaucher disease: correlation with phenotype and genotype <i>Mol Genet Metab<\/i>, 76, pp. 262 - 70.","journal-title":"Mol Genet Metab"},{"key":"E00006","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.nbd.2003.08.016","volume":"14","author":"Schueler UH","year":"2003","unstructured":"Schueler, UH and Kolter, T and Kaneski, CR and Bluzsztajn, JK and Herkenham, M and Sandh, K and (2003) Toxicity of glucosylsphingosine (glucopsychosine) to cultured neuronal cells: a model system for assessing neuronal damage in Gaucher disease type 2 and 3 <i>Neurobiol Dis<\/i>, 14, pp. 595 - 601.","journal-title":"Neurobiol Dis"},{"key":"E00007","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/BF00690463","volume":"65","author":"Conradi NG","year":"1984","unstructured":"Conradi, NG and Sourander, P and Nilsson, O and Svennerholm, L and Erikson, A. (1984) Neuropathology of the Norrbottnian type of Gaucher disease, morphological and biochemical studies <i>Acta Neuropathol (Berl)<\/i>, 65, pp. 99 - 109.","journal-title":"Acta Neuropathol (Berl)"},{"key":"E00008","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1056\/NEJM199105233242104","volume":"324","author":"Barton NW","year":"1991","unstructured":"Barton, NW and Brady, RO and Dambrosia, JM and Di Bisceglie, AM and Doppelt, SH and Hill, SC and (1991) Replacement therapy for inherited enzyme deficiency \u2013 macrophage targeted glucocerebrosidase for Gaucher's disease <i>N Engl J Med<\/i>, 324, pp. 1464 - 70.","journal-title":"N Engl J Med"},{"key":"E00009","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0002-9343(02)01150-6","volume":"113","author":"Weinreb NJ","year":"2002","unstructured":"Weinreb, NJ and Charrow, J and Andersson, HC and Kaplan, P and Kolodny, EH and Mistry, I and (2002) Effectiveness of enzyme replacement therapy in 1028 patients with type 1 Gaucher disease after 2 to 5 years of treatment: a report from the Gaucher Registry <i>Am J Med<\/i>, 113, pp. 112 - 9.","journal-title":"Am J Med"},{"key":"E00010","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1055\/s-2008-1071549","volume":"24","author":"Erikson A","year":"1993","unstructured":"Erikson, A and Johansson, K and M\u00e5nsson, JE and Svennerholm, L. (1993) Enzyme replacement therapy of infantile Gaucher disease <i>Neuropediatrics<\/i>, 24, pp. 237 - 8.","journal-title":"Neuropediatrics"},{"key":"E00011","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1067\/mpd.2001.112171","volume":"38","author":"Altarescu G","year":"2001","unstructured":"Altarescu, G and Hill, S and Wiggs, E and Jeffries, N and Kreps, C and Parker, CC and (2001) The efficacy of enzyme replacement therapy in patients with chronic neuronopathic Gaucher's disease <i>J Pediatr<\/i>, 38, pp. 539 - 47.","journal-title":"J Pediatr"},{"key":"E00012","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/S0950-3536(97)80035-2","volume":"10","author":"Erikson A","year":"1997","unstructured":"Erikson, A and Bembi, B and Schiffman, R. (1997) Neuronopathic forms of Gaucher's disease <i>Baillieres Clin Hematol<\/i>, 10, pp. 711 - 23.","journal-title":"Baillieres Clin Hematol"},{"key":"E00013","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1212\/01.WNL.0000130191.31669.48","volume":"63","author":"Campbell PE","year":"2004","unstructured":"Campbell, PE and Harris, CM and Vellodi, A. (2004) Deterioration of the auditory brainstem response in children with type 3 Gaucher disease <i>Neurology<\/i>, 63, pp. 385 - 7.","journal-title":"Neurology"},{"key":"E00014","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1651-2227.1986.tb14936.x","volume":"326","author":"Erikson A","year":"1986","unstructured":"Erikson, A. (1986) Gaucher disease \u2013 Norrbottnian type (III). Neuropaediatric and neurobiological aspects of clinical patterns and treatment <i>Acta Paediatr Scand Suppl<\/i>, 326, pp. 1 - 42.","journal-title":"Acta Paediatr Scand Suppl"},{"key":"E00015","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0887-8994(87)90033-6","volume":"3","author":"Erikson A","year":"1987","unstructured":"Erikson, A and Karlberg, J and Skogman, AL and Dreborg, S. (1987) Gaucher disease (type III): intellectual profile <i>Pediatr Neurol<\/i>, 3, pp. 87 - 91.","journal-title":"Pediatr Neurol"},{"key":"E00016","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1182\/blood-2003-05-1612","volume":"103","author":"Boot RG","year":"2004","unstructured":"Boot, RG and Verhoek, M and de Fost, M and Hollak, CE and Maas, M and Bleilevens, B and (2004) Marked elevation of the chemokine CCL18\/PARC in Gaucher disease: a novel surrogate marker for assessing therapeutic intervention <i>Blood<\/i>, 103, pp. 33 - 9.","journal-title":"Blood"},{"key":"E00017","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1055\/s-2007-979754","volume":"26","author":"Erikson A","year":"1995","unstructured":"Erikson, A and \u00c5str\u00f6m, M and M\u00e5nsson, JE. (1995) Enzyme infusion therapy of the Norrbottnian (Type 3) Gaucher disease <i>Neuropediatrics<\/i>, 26, pp. 203 - 7.","journal-title":"Neuropediatrics"},{"key":"E00018","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1399-0004.1982.tb01445.x","volume":"22","author":"Nilsson O","year":"1982","unstructured":"Nilsson, O and H\u00e5kansson, G and Dreborg, S and Groth, CG and Svennerholm, L. (1982) Increased cerebroside concentration in plasma and erythrocytes in Gaucher disease: Significant differences between type I and type III <i>Clin Genet<\/i>, 22, pp. 274 - 9.","journal-title":"Clin Genet"},{"key":"E00019","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1111\/j.1471-4159.1987.tb02435.x","volume":"49","author":"Svennerholm L","year":"1987","unstructured":"Svennerholm, L and Fredman, P and Jungbjer, B and M\u00e5nsson, JE and Rynmark, BM and Bostr\u00f6m, K and (1987) Large alterations in ganglioside and neutral glycosphingolipid patterns in brains from cases with infantile neuronal ceroidlipofuscinosis\/poly-unsaturated fatty acid lipidosis <i>J Neurochem<\/i>, 49, pp. 1772 - 83.","journal-title":"J Neurochem"},{"key":"E00020","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1172\/JCI117084","volume":"93","author":"Hollak CE","year":"1994","unstructured":"Hollak, CE and van Weely, S and van Oers, MH and Aerts, JM. (1994) Marked elevation of plasma chitotriosidase activity, a novel hallmark of Gaucher disease <i>J Clin Invest<\/i>, 93, pp. 1288 - 92.","journal-title":"J Clin Invest"},{"key":"E00021","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1023\/A:1010514614570","volume":"24","author":"Vellodi A","year":"2001","unstructured":"Vellodi, A and Bembi, B and de Villemeur, TB and Collin Histed, T and Erikson, A and Mengel, E and (2001) Management of neuronopathic Gaucher disease: a European consensus <i>J Inherit Metab Dis<\/i>, 24, pp. 319 - 27.","journal-title":"J Inherit Metab Dis"}],"container-title":["Acta Paediatrica"],"original-title":[],"link":[{"URL":"http:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1080%2F08035250500423804","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1080\/08035250500423804\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,10]],"date-time":"2021-02-10T16:38:51Z","timestamp":1612975131000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1080\/08035250500423804"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3,1]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,3,1]]}},"alternative-id":["X061861663387337"],"URL":"https:\/\/doi.org\/10.1080\/08035250500423804","relation":{},"ISSN":["0803-5253"],"issn-type":[{"value":"0803-5253","type":"print"}],"subject":[],"published":{"date-parts":[[2006,3,1]]}}}